Averting Cancer: The Economic Case for Expanding HPV Vaccination
Abstract
I have come across the study entitled “Cost-Utility Analysis of Expanding Human Papillomavirus Vaccination to Adult Women in Indonesia: A Markov Model Approach,” by Hidayati, Endarti, and Setiawan. The study’s significance and scientific contribution come from using the technique of a Markov model to show how cost-effective it is to vaccinate adult Indonesian women against HPV in addition to adolescents.
A
more comprehensive vaccination program might be an effective use of
public health resources because it can lower the incidence of cervical
cancer being a wise financial investment, according to this thorough,
model-based approach. It shifts the discussion from the vaccine’s
clinical effectiveness to its economic worth, which is essential for
guiding public health policy in environments with limited resources.
Authors
John Patrick C. Toledo